E&PH Responds to COVID-19

E&PH Faculty "On the Record"

*In chronological order (from newest to oldest)

*Note: these stories are tracked in real time on our @StanfordEpiNews twitter feed. Follow us to stay abreast of Epi COVID-19 News! Also note, this list is not a comprehensive list of all core faculty media appearances during this period, but rather a showcase of department highlights and key moments in the COVID-19 conversation.

October 18, 2020. Population health scientist and epidemiologist Mark Cullen provides his expert opinion on how to plan a safe, small Bay Area holiday gathering during the pandemic.
San Francisco Chronicle

October 14, 2020. Steve Goodman is quoted in this Science Magazine story that explains why the world will likely benefit from having more than one COVID-19 vaccine, because of the needs of different populations and so that supply can meet demand.
Science Magazine

October 14, 2020. Yvonne Maldonado explains why COVID-19 vaccines may not initially be recommended for children, "It is important that safety data are accrued in adult trials before vaccines or other therapeutics are tested in children.”
Yahoo News

October 14, 2020. Epidemiologist Yvonne Maldonado, MD, is quoted in this San Francisco Chronicle story about how California will distribute COVID-19 vaccines, and the Bay Area's plan for dealing with multiple scenarios.
San Francisco Chronicle

October 13, 2020. Epidemiologist Yvonne Maldonado, MD, shares her thoughts on what comes next in the suspended Johnson & Johnson COVID-19 vaccine trial, "Virtually every trial will have an adverse event."
ABC News

October 12, 2020. Yvonne Maldonado, MD, is featured in this San Francisco Chronicle story, with an update on the state of COVID-19 testing options.
San Francisco Chronicle

October 6, 2020. Stanford University, CZ Biohub and a group of collaborators have created a low-cost system to collect samples for COVID-19 testing and monitor populations for the disease. Yvonne Maldonado discusses the Vera system in this segment.
ABC News

October 6, 2020. Eight months into the COVID-19 pandemic, the move toward saliva screening is gaining traction, with tens of thousands of people across the country undergoing such testing daily. Yvonne Maldonado is quoted in this LA Times story.
Los Angeles Times

October 3, 2020. The experimental drug given to President Trump for COVID-19 is being studied by Bay Area researchers who believe it could help people with mild/moderate symptoms recover faster, or stop them from worsening. Yvonne Maldonado, MD, is quoted.
San Francisco Chronicle

October 2, 2020. Epidemiologist and infectious disease expert Yvonne Maldonado, MD, discusses President Trump's COVID-19 diagnosis and his level of risk for complications in this CBS News story.
CBS News